Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zogenix Inc
(NQ:
ZGNX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 4, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
26.68 (8)
Ask (Size)
26.79 (5)
Prev. Close
26.68
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
56,228,303
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
March 25, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
March 20, 2022
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...
Via
Benzinga
Performance
More News
Read More
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
March 02, 2022
Via
Benzinga
Merger Arbitrage Mondays - Healthcare Trust Of America To Combine With Healthcare Realty Trust
March 07, 2022
Via
Benzinga
Recap: Zogenix Q4 Earnings
February 28, 2022
Via
Benzinga
Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them?
February 17, 2022
Via
Investor's Business Daily
The Week Ahead In Biotech (Jan. 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, & More
January 23, 2022
Via
Talk Markets
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
January 23, 2022
Via
Benzinga
Mid-Afternoon Market Update: Dow Tumbles 150 Points; Yumanity Therapeutics Shares Plunge
January 19, 2022
Via
Benzinga
SBEV Stock: The Ralph’s Grocery Deal Making Waves for Splash Beverage Group Today
January 19, 2022
Via
InvestorPlace
52 Biggest Movers From Yesterday
January 20, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 19, 2022
Via
Benzinga
Mid-Day Market Update: US Stocks Turn Negative; Zogenix Shares Spike Higher
January 19, 2022
Via
Benzinga
Zogenix (ZGNX) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Zogenix, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ZGNX
January 19, 2022
From
Halper Sadeh LLP
Via
Business Wire
GENI Stock: The Analyst Call Sending Genius Sports Shares Surging Today
January 19, 2022
Via
InvestorPlace
35 Stocks Moving In Wednesday's Mid-Day Session
January 19, 2022
Via
Benzinga
ZGNX Stock: The $1.9B UCB Deal That Has Zogenix Shares Zooming Higher Today
January 19, 2022
Via
InvestorPlace
Mid-Morning Market Update: Markets Rise; Bank of America Posts Upbeat Profit
January 19, 2022
Via
Benzinga
Zogenix Nabs $1.9 Billion Takeover As Epilepsy Drug Piques UCB Interest
January 19, 2022
Via
Investor's Business Daily
Why Zogenix Shares Are Soaring Today
January 19, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 19, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 19, 2022
Via
InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
January 19, 2022
Via
Benzinga
UCB to Buy Epilepsy-Focused Zogenix In $1.9B Deal: See The Highlights
January 19, 2022
Via
Benzinga
61 Biggest Movers From Yesterday
December 02, 2021
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.